Tricida, Inc(NASDAQ:TCDA) 
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of TRC101, a non-absorbed orally-administered polymer that has completed phase 3 trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gas...
Website: http://www.tricida.com
Founded: 2013
Full Time Employees: 64 (May 2021)
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-01-23
P
O 0.12
H 0.12
L 0.09
C 0.11
V 31,125,300
10EMA 0.11
20EMA 0.11
60EMA 0.11
120EMA 0.11
250EMA 0.11